Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Yun Wu, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and New York. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2003 - 2004
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2003
- Shanghai Medical UniversityClass of 1991
Certifications & Licensure
- TX State Medical License 2003 - 2026
- NY State Medical License 2002 - 2010
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Prospective and retrospective analysis of whole slide images of sentinel and targeted lymph node frozen sections in breast cancer.Qiqi Ye, Timothy Law, Dianna Klippel, Constance Albarracin, Hui Chen
Modern Pathology. 2025-01-07 - Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.Haydee Del Calvo, Yun Wu, Heather Y Lin, Elise F Nassif, Maria A Zarzour
Annals of Surgical Oncology. 2024-11-01 - 3 citationsNuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma.Qiqi Ye, Hui Chen, Cody Han, Yan Peng, Xiao Huang
Journal of Clinical Pathology. 2024-10-20
Press Mentions
- Students Present Their Summer Research ProjectsSeptember 13th, 2021
- AACR21 Preview: Discovery Science Driving Clinical BreakthroughsApril 5th, 2021
- Sfrp1 Protects Against Acute Myocardial Ischemia (AMI) Injury in Aged Mice by Inhibiting the Wnt/Β-catenin Signaling PathwayJanuary 19th, 2021